Daniel Gene Hamilton

Author:

Daniel Hamilton

ISBN #:

0934066019

Author:

Daniel S. Hamilton

ISBN #:

0870030523

Author:

Daniel W. Hamilton

ISBN #:

0226314820

US Patent:

8566286, Oct 22, 2013

Filed:

Feb 5, 2010

Appl. No.:

12/700799

Inventors:

Brett Derek Hawton - Alamo CA, US
Barry John Searle - Randburg, ZA
Daniel Aaron Hamilton - Pearland TX, US

Assignee:

Idera, Inc. - Houston TX

International Classification:

G06F 17/30

US Classification:

707654

Abstract:

A system and method for backing up a database, where the system has read threads running simultaneously, write threads, and data buffers. Each read thread repeats the following operations until all the data is backed up: read a block of data from the database, compress the data using a dynamic compression ratio which is initialized and adjusted after every compression, write the data to an available data buffer until the data buffer is full, write to the next available data buffer once the data buffer is full, and determine a new compression ratio. A controller determines the new compression ratio using either a method that monitors the timing of system components and/or a method that monitors CPU consumption.

US Patent:

20120130487, May 24, 2012

Filed:

Nov 24, 2010

Appl. No.:

12/954424

Inventors:

Anand Doraiswamy - Goleta CA, US
Jensen Buck - Goleta CA, US
Daniel Hamilton - Napa CA, US

International Classification:

A61F 2/16

US Classification:

623 643

Abstract:

An intraocular lens comprises an optic and at least two haptics, each of which comprises a step feature that protrudes from a posterior surface of the haptic to prevent posterior capsular opacification.

US Patent:

20120130488, May 24, 2012

Filed:

Nov 29, 2010

Appl. No.:

12/955654

Inventors:

Anand Doraiswamy - Goleta CA, US
Jensen Buck - Goleta CA, US
Daniel Hamilton - Napa CA, US

International Classification:

A61F 2/16

US Classification:

623 643

Abstract:

An intraocular lens comprises an optic and at least two haptics. Each haptic is offset in an anterior direction from a central optic plane of the optic. The offset allows for predictable posterior vaulting upon implantation.

US Patent:

20210370051, Dec 2, 2021

Filed:

Feb 1, 2021

Appl. No.:

17/164709

Inventors:

- San Francisco CA, US
Daniel N. Hamilton - Napa CA, US
Manfred Franke - Valencia CA, US
Douglas Michael Ackermann - Reno NV, US

International Classification:

A61N 1/05
A61N 1/36

Abstract:

Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.

US Patent:

20200030615, Jan 30, 2020

Filed:

Oct 8, 2019

Appl. No.:

16/595846

Inventors:

- San Francisco CA, US
Manfred Franke - Redwood City CA, US
Daniel N. Hamilton - Napa CA, US
Anand Doraiswamy - San Francisco CA, US
Douglas Michael Ackermann - San Francisco CA, US

International Classification:

A61N 1/378
A61N 1/375
A61N 1/36
B29D 11/00

Abstract:

Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.

US Patent:

20190308009, Oct 10, 2019

Filed:

Mar 18, 2019

Appl. No.:

16/357033

Inventors:

- South San Francisco CA, US
Daniel N. Hamilton - Napa CA, US
Manfred Franke - Valencia CA, US
Douglas Michael Ackermann - San Francisco CA, US

International Classification:

A61N 1/05
A61N 1/36

Abstract:

Described here are devices, systems, and methods for treating one or more conditions, such as allergic rhinitis, non-allergic rhinitis, nasal congestion, ocular allergy, and/or symptoms associated with these conditions, by providing stimulation to nasal or sinus tissue. In some variations, the handheld devices may have a stimulator body and a stimulator probe having one or more nasal insertion prongs, and the nasal insertion prongs may be configured to deliver an electrical stimulus to the tissue.

US Patent:

20170368359, Dec 28, 2017

Filed:

Sep 8, 2017

Appl. No.:

15/699905

Inventors:

- South San Francisco CA, US
Manfred FRANKE - Valencia CA, US
Daniel N. HAMILTON - Napa CA, US
Anand DORAISWAMY - San Francisco CA, US
Douglas Michael ACKERMANN - Reno NV, US

International Classification:

A61N 1/378
A61N 1/36

Abstract:

Described here are devices, systems, and methods for increasing tear production by stimulating the cornea, conjunctiva, and/or subconjunctiva. In some variations, the devices may be in the form of a contact lens. The contact lens may comprise a lens body and a stimulator chip, where the stimulator chip is embedded in the lens body. An external power source wirelessly transmits energy to the stimulator chip, where the stimulator chip may convert the energy to an electric waveform to stimulate the cornea, conjunctiva, and/or subconjunctiva. Stimulation may activate the lacrimal reflex to increase tear production. The devices and systems for increasing tear production may be used in methods of treating dry eye, reducing the symptoms of tired eye, increasing comfort for contact lens wearers, and extending the number of years a contact lens user can wear contacts. Also described are methods of manufacturing a contact lens.

US Patent:

20170312521, Nov 2, 2017

Filed:

May 2, 2017

Appl. No.:

15/584956

Inventors:

- South San Francisco CA, US
Diane Michelle SENCHYNA - Corona del Mar CA, US
Daniel N. HAMILTON - Napa CA, US

International Classification:

A61N 1/36
A61N 1/36
A61N 1/05

Abstract:

Described here are devices, systems, and methods for treating meibomian gland disease and/or blepharitis by providing intranasal stimulation. Generally, the devices may deliver electrical stimulation to the nasal mucosa. Intranasal stimulation may unblock obstructed meibomian glands and increase the lipid content of tears, both acutely during stimulation and subsequent to intranasal stimulation. The methods may include an initial round of stimulation to unblock obstructed meibomian glands, and subsequent shorter rounds of stimulation to cause meibum secretion and maintain the open glands.